Webinar Replay: What You Should Know About MDR Best Practices, Including PMCF

On-Demand Webinar

The Medical Device Regulation (MDR) 745/2017, published in 2017, established a stricter and more uniform regulatory framework for the European Union with the goal of improving the clinical safety of the devices. Today, all medical devices in Europe must comply with the MDR yet many companies are still facing difficulties navigating these new regulations. 

In this webinar, sponsored by Alira Health and MassMedic, we review major changes introduced by the MDR. We focus on the post-market requirements, especially the Post-Market Clinical Follow-up (PMCF). Our panel of experts also shares their experiences with the new MDR regulation and offer best practices for companies in the middle of, or about to start, their own MDR journey. 

We can help you navigate PMCF across the entire lifecycle of your MedTech products. 

Published on:
July 12, 2022
The Speakers

Anagha Karnik

Director, Regulatory Affairs, Edwards Lifesciences Anagha has extensive experience in the medical device industry with a proven track record building strong regulatory affairs teams for product development and sustaining manufacturing of Class II and Class III medical devices including cardiovascular, endovascular, IVDs, polymers and has been responsible for bringing several devices to market. Her regulatory experience covers EFS IDEs, pivotal IDEs, Modular PMAs, 510(k)s, CE Marking - MDD Design Dossiers, Technical Files, MDR Technical Documentation (TD), International Dossiers, Clinical Evaluation Reports (CERs), Ad/Promo reviews, product claims/substantiation and market adoption strategies as well as successful domestic and international regulatory authority(ies) interactions and negotiations.

Arthi Chandran

Divisional Vice President, Health Economics and Reimbursement, Abbott Arthi has been a leader in both US and Global roles and is focused on driving public health outcomes while delivering commercial growth in highly competitive markets. In her 15+ year career, in the Medtech and Pharmaceutical industries, Arthi has been recognized for embedding a practice of value demonstration and communication through differentiated evidence generation strategies and accompanying economic tools. She has championed, and continues to drive the proliferation of, cross-functional approaches to innovation and market development to secure broader access to, and adoption of, health care technologies.

Arthi holds an MPH in Chronic Disease Epidemiology from Yale University, an MS in Regulatory Affairs from Temple University and a Doctorate in Health Policy and Management from the City University of New York.

Related news

Publications November 22, 2022
External Control Arms: The Way to Go?
The growing implementation of Single Arm Trials (SATs) with External Control Arms (ECAs) has been the subject of heated debate across Europe.
Clinical Trials Regulatory
Multimedia October 27, 2022
RARECast: Leveraging Technology to Empower Patients and Decentralize Clinical Trials
Technology plays a central role in the future of patient empowerment and decentralized clinical trials. Listen to the podcast to learn more.
Decentralized Clinical Trials MedTech
Multimedia October 13, 2022
Exclusive MedTech Webinar Series “Expanding Beyond APAC”
Join this series of webinars to learn about the strategies, challenges, and best practices of scaling beyond the Asia Pacific MedTech market.
Events October 7, 2022
Debate Sobre los IPT en Oncología
We are pleased to announce our next event, “Debate Sobre los IPT en Oncología,” focusing on price and reimbursement (P&R) of vital oncology and oncohematology therapies.
Market Access Product Development Regulatory
Events October 6, 2022
The MedTech Conference 2022
We are pleased to share that we will be joining the MedTech Conference 2022 as sponsors and speakers! This year’s edition will have more than 100 sessions focusing on today’s hot topics.
M&A MedTech Regulatory
News October 4, 2022
Alira Health enhances its market access services through a strategic partnership with Centivis
Alira Health, a global healthcare advisory and technology company, announced a strategic partnership with Centivis AG, a boutique market access consulting agency, specializing in digital(...)
Digital Health Market Access MedTech Pharma Regulatory
Multimedia September 29, 2022
Webinar Replay: Regulatory Strategy for Registering Rare Disease Products in the EU
In this webinar we will focus on how to benefit, today and in the future, from the orphan drug program and build a regulatory strategy for successful rare disease product registration(...)
Drug Development Rare Disease Regulatory
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.